Ubundlobongela, iziyobisi kunye nobutyebi: Indlela i-Brain Controls Ekhuthazwa ngayo izakhono (2011)

Elaine M. Hull*

Physiol Behav. I-2011 Julayi 25; 104(1): 173-177.

Ishicilelwe kwi-intanethi 2011 Meyi 5. ikhonkco:  10.1016 / j.physbeh.2011.04.057

Abstract

U-Bart Hoebel wenze umbono wokuba uthungelwano oluhlanganisiweyo lwe-neural oluyalela phakathi imbuyekezo yendalo kunye nokusetyenziswa kweziyobisi. Uvulele ukuba kusetyenziswe i-microdialysis, kwaye wasebenzisa ngokufanelekileyo ukukhuthaza umbane, izilonda, ii-microinjections, kunye ne-immunohistochemistry. Wafumanisa ukuba ukondla, ukulawula iziyobisi, kunye nokukhuthaza kombane kwi-hypothalamus (LH) eyonyukayo yonke ukukhutshwa kwe-dopamine (DA) kwi-nucleus accumbens (NAc). Nangona kunjalo, ngelixa iDA kwi-NAc iphuculwe inkuthazo, iDA kwi-LH inqabile ekuziphatheni okuzinzileyo. I-Hull lab ilandele ezinye zezo zimvo. Sicebise ukuba i-serotonin (5-HT) kwi-pervivicalLH inhibit yokuziphatha ngokwesondo ngokuthintela i-orexin / hypocretin neurons (OX / HCRT), eya kuthi ngenye indlela ixhase ii-neurons kwiphecana le-mesocorticolimbic DA. Sibonisile ukuba ukukhutshwa kwe-DA kwindawo ye-medial preoptic (MPOA) kubaluleke kakhulu ekuziphatheni ngokwesini kwamadoda, kwaye ukuba i-testosterone, glutamate, nitric oxide (NO) kunye namava ezesondo angaphambili akhuthaza ukukhutshwa kwe-MPOA DA nokukhula komtshato. Uphando lwexesha elizayo kufuneka lulandele ugxininiso lukaBart Hoebel kwiinkqubo ze-neural kunye nokusebenzisana phakathi kweendawo zengqondo kunye ne-neurotransmitters.

Internet: I-Dopamine, i-Serotonin, indawo ye-Medic preoptic, indawo ye-Mesocorticolimbic, iTestosterone, i-Nitric oxide, i-Orexin / hypocretin, i-Glutamate, uKopisho.

1. Uphando lukaBart Hoebel

U-Bart Hoebel ngumntu omkhulu phakathi kwe-neuroscientologists. Uye wangenela ubuchwephesha obutsha kwaye wavelisa ukuqonda okungaphaya kokusebenza kwengqondo. Ukusetyenziswa kwakhe kwe-micodialysis kunye nokusebenza okuphezulu kwe-chromatography ye-fluid (HPLC) ukuqokelela kunye nokuhlalutya ii-neurotransmitters kwiindawo ezahlukeneyo zobuchopho zibonelela ngengqondo ebalulekileyo malunga nokusebenzisana phakathi kwe-hypothalamus kunye nenkqubo ye-mesocorticolimbic dopamine (DA). Umsebenzi wam omninzi ukwiindlela awazisekayo.

Inqaku lakhe lokuqala, lipapashwe ngaphakathi inzululwazi, ingxelo yokuba ukusetyenziswa kokutya kuthintele, kungekuko ukondla kuphela, kodwa nokuzivuselela ngokwasemva, kunye nokuba i-ventromedial hypothalamus iphakathi1]. Okwesibini inzululwazi Inqaku longeze isifundo sakhe malunga neendlela zokuziphatha ezibandakanyiweyo ukubandakanya ukupopolwa. Yachaza ukuba ukhuthazo lombane lwe-hypothalamus yangemva yonyusa ukukhuthaza kunye nokukhuthaza umvuzo wokulinganisa [2]. Usafunda ukubophela, waba nomdla kwindima ye-serotonin (5-HT) kummiselo wayo. Inaliti eyenzekileyo ye-p-chloroamphetamine (PCA) inhibosis yababhinqileyo bengamakhosi ngenxa yokukhutshwa kwe5-HT. Nangona kunjalo, i-PCA engapheliyo iququzelele i-Lordosis, ngenxa ye-5-HT depletion [3]. Ke ngoko, i-5-HT yayinefuthe ekuziphatheni ngokwesini kwabasetyhini.

U-Bart Hoebel kamva waba nobuchule kwi-microdialysis, kunye ne-dopamine (DA), i-serotonin (5-HT), kunye ne-acetylcholine (ACh) eza ngaphambili. Ukutya, i-cocaine, kunye nokuzilawula okwenzeka emva kwexesha, konke ukunyusa kwe-DA kwiphecana ye-mesocorticolimbic ye-DA [4, 5, 6]. Ngaphaya koko, bekukho ukungqubana okungalindelekanga phakathi kweendawo zobuchopho. Umzekelo, bekukho ubudlelwane obungenanto phakathi kweziphumo ze-DA kwi-lateral hypothalamus (LH) vs the NAc [7]. I-DA kwi-LH yayingemnandi kwaye ibathintele ekuziphatheni okuqinisekileyo, kodwa iDA kwi-NAc yayinembuyekezo kwaye ikhuthaza isimilo esichazayo.

2. Uphando lweelebhu

Ilebhu yam ilandelele ezinye zezi mbono. Sisebenzise i-microdialysis, i-microinjection, kunye ne-immunohistochemistry, kunye novavanyo lokuziphatha, ukuphanda ukujikeleza okuphakathi kokuziphatha kwendoda yesini.

2.1. Iziphumo ze-5-HT kwi-LH engaphandle

Umfundi wam wangaphambili uDan Lorrain wasebenzisa i-Microdialysis ukubonisa ukuba i-5-HT ikhutshwa kwi-LH engaphandle ngexesha le-ejaculation [8] (jonga Ikhiwane. 1), kanye njengokuba uBart Hoebel wayexele ukukhutshwa kwe5-HT apho ngokondla [9]. Ngaphaya koko, i-microinjection ye-anhibitake inhibitor ekhethiweyo ye-5-HT kwi-LH engqinelwanga, efana ne-post-ejaculatory quiescence kunye neziphumo ebezingalindelekanga zesondo ezichasene ne-SSRI ezisetyenziselwa ukunyanga uxinzelelo. Ke, ilebhu yeHoebel ibonise ukuba ukwanda okucwangcisiweyo kwi-5-HT engalunganga yokuziphatha kwezesondo kwabasetyhini [10], kunye ne-Hull lab ebekwe kwindawo enye yobuchopho, i-anterior LH, apho i-5-HT yendawo inyusa indlela yokuziphatha yesini yowesilisa [8]. Kwinqaku emva kwexesha, sixele ukuba ukuphinda-dialysis kwe-5-HT kwi-anterior (pericileical) LH kunciphise ukukhutshwa kwe-DA kwi-NAc [11]. Ke ngoko, ukukhutshwa kwe-5-HT kwi-LH ngexesha le-ejaculation kunganegalelo kwi-post-ejaculatory quiescence, ubuncinci ngenxalenye, ngokuthintela indlela ye-mesocorticolimbic ye-DA.

Ikhiwane. 1     

Ikhiwane. 1

 

Utshintsho lwexeshana kwi-serotonin ye-extracellular (5-HT) eqokelelwe kwi-hypothalamus ye-lateral yeerhasi zamadoda ngaphambili nangexesha lokuprinta. Indawo nganye yedatha yintsingiselo (± SEM) yeesampulu zidayalate ze-6-min eziqokelelwe ngexesha lokwandlalela (B), phambi komfazi osisidalwa (F), ngexesha lokushicilela (C), ngexesha lokuphumla emva kokubhengeza umzimba (P), nasemva kokuba inkosikazi isusiwe (ichazwe njenge-% yamanqanaba okusisiseko asisiseko). Amanqanaba e-5-HT anyuke ngexesha lesibini (P2) nelesithathu (P3) emva kwexesha kwisiseko sokugqibela. I-5-HT ngexesha le-P3 nayo yayiphezulu kunakwithuba lesine lokushicilela. Amasampulu aqokelelwe ngexesha lesibini nelesithathu lokukhuphela awuzange ahlaziywe, kuba uninzi lwamadoda luyekiswe ngaphambi kokuba isampulu ye-6-min epheleleyo iqokelele. Igrafu esisishwankathelo (i-inset) ibonisa intsingiselo (± SEM) yedatha yamaxesha esampulu ye-15 ehlelwe ngokwamaqela amahlanu, ngokusekwe kwimeko yokuziphatha. Amasampulu aqokelelwe ngexesha lasemva kwe-ejaculatory intervals abonise amanqanaba aphezulu e-5-HT kunezinye iimeko zonke. (Umzobo [8Ngemvume.)

 

2.2. I-OX / HCRT kwi-hyperalamus yangaphandle

Kutshanje sinikeze ngokulandelelana kwebali le-hypothalamic 5-HT. Iqela le-neurons kwi-LH livelisa i-peptide orexin (OX, ekwabizwa ngokuba yi-hypocretin, HCRT). Ngaphaya koko, i-5-HT ngaphambili yayixelwe ukuba ibangela ezo ntsholongwane (12). I-OX / HCRT iyaziwa ngokukhuthaza indlela yokuziphatha13,14] nokulawulwa kwemijikelezo yokuvuka kokulala [15, 16]. I-OX / HCRT-equlathe ii-neurons ibikade ixelwe kwi-projekti ukuya kwindawo yecandelo le-ventral tegmental (VTA) [17], umthombo we-mesocorticolimibc DA iphecana. Ngapha koko, kwaxelwa ukuba i-Intra-VTA yolawulo lwe-OX / HCRT inyusa ukukhutshwa kwe-DA kwi-NAc [18]. Umfundi wam wangaphambili uJohn Muschamp wathi hypotalamic neurons eyayithintelwe yi-post-ejaculatory 5-HT inokuba ziiseli ezi-OX / HCRT. Sibonisile ukuba ukonyusa ukukhula kwe-c-Fos-immunoreactivity kwi-OX / HCRT-cell cell [19]. Ukongeza, ukusasazeka kwehlile inani le-OX / HCRT-immunoreactive neurons, ezazibuyiselwa kakhulu ngenaliti ye-estradiol. I-OX / HCRT ichaphazela indlela yokuziphatha, njengolawulo lwenkqubo ye-OX / HCRT19]. Ukongeza, i-microinjection ye-OX / HCRT kwi-VTA yavelisa iziphumo ezixhomekeke kumthamo wokudubula kweseli dopaminergic. Iidosi ezimbini ezisezantsi zonyuse ukudubula kweseli kunye neempendulo zabemi, nangona eyona dosi iphezuluyo yakhokelela ekubethelelweni kwe-VTA dopaminergic neurons, ethe yatshintshwa ngokuvuselela ii-autoreceptors ze-DA nge-apomistphine ye-DA. Okokugqibela, ukuphinda-phinda kabini i-immunohistochemistry kutyhila ukuba ukuvuthwa kukonyusa i-c-Fosimmunoreactivity kwi-dopaminergic neurons kwi-VTA eyayifakwe kwi-OX / HCRT fibers. Ke, ii-neurons ze-OX / HCRT zibonakala zisebenza ngendlela exhomekeke kwi-steroid ukuvula indlela ye-mesocorticolimbic ye-DA, ngaloo ndlela ikhuthaza indlela yokuziphatha ngokwesondo kunye neminye imbuyekezo yendalo kunye neziyobisi.

2.3. Ukukhutshwa kwe-DA kwindawo ye-medial preoptic (MPOA)

Ukongeza kwi-LH kunye ne-mesocorticolimbic ye-DA inkqubo, ilebhu yam iye yaphanda indima ye-MPOA, kwindawo engaphandle yengqondo ye-hypothalamus, kulawulo lokuziphatha ngokwesondo kwamadoda. Izilonda ze-MPOA ziphazamisa ukusebenza ngokwesondo kwamadoda kuzo zonke iintlobo zezilwanyana ezifundileyo (ezihlaziyiweyo kwi- [20]). Ukunyuswa kombane okanye kweekhemikhali ze-MPOA kuphucula ukwenziwa kunye ex ikopi Iimpawu zesini zesini. I-neurons yengingqi ye-A14 ejikeleze i-neurons ye-DA yangaphakathi kwi-MPOA, njengoko kwenza i-neurons ze-DA ezivela kwezinye iisayithi [21].

Kukho unxibelelwano olusondeleyo phakathi kwendlela yokuziphatha kwamadoda esini kunye nenqanaba le-DA yangaphandle kwi-MPOA. I-DA ikhutshwa kwi-MPOA yeempuku zamadoda ukuphendula kumfazi ophakathi kunye nangexesha lokukhutshwa [22] (jonga Ikhiwane. 2). Ubukho bamva nje be testosterone bebuyimfuneko kokubini ukukhutshwa kwe-DA kunye nokuprintwa. Amadoda anomdla, i-testosterone-yanyangwa i-castrate, kunye ne-castrate eziphathwe ngeoyile ezakhutshelweyo zibonisa ukwanda kwangaphambili kwe-DA, eyayigcinwa okanye yanda ngakumbi ngexesha lokuzala [22, 23]. Ii-castrate eziphathwe ioyile ezingakhange zikopele zingabonisanga nyuso. Kwakukho zombini isimilo sokuziphatha kunye nokungaqondakali kwimpendulo ye-DA. Ngapha koko, isibakala sokuba i-DA inyuke ngaphambi kokuqala kokuzala ibonisa ukuba ukunyuka akubangelwa kukukhuphela, kodwa kusenokwenzeka ukuba kuyayanyaniswa nezizathu zesondo. Iibini, ezintlanu-, kunye neerejimeni zentsuku ezilishumi zokunyangwa kwe-testosterone ye-castrate zikhokelela ekukhuliseni amandla okuprinta okuhambelana kakhulu nokubuyiselwa kokukhutshwa kwe-DA [24]. Unyango lwe-testosterone yeentsuku ezimbini alubuyanga mating okanye impendulo ye-DA. Uninzi lweentsuku ezintlanu ze-testosterone eziphathwe nge-testosterone zazikwazi ukukopa kwaye zibonisa impendulo ye-DA, ngesiqingatha sazo sikwazi ukujikisa. Zonke i-castrate ziphathwe nge testosterone yeentsuku ze-10 zidityaniswe kwi-ejaculation, kwaye zonke zabonisa impendulo ye-DA. Kwakukho ukunxibelelana okuninzi phakathi kwamanyathelo okukhusa kunye namanqanaba e-DA. Ke ngoko, zombini ukuphulukana kweprotocol kulandela ukuthunyelwa kunye nokubuyiselwa kwayo nge-testosterone kunxulunyaniswa ngokusondeleyo nempendulo ye-MPOA ye-DA kumfazi oguqukayo.

Ikhiwane. 2     

Ikhiwane. 2

 

Ukuphuculwa kwe-testosterone-Mediated kwento yesondo kunokuba kwenzeka ngokwenyusa ukukhutshwa kwe-DA kwi-MPOA. Iigundane ezingaconjwanga kakuhle zamaduna zibonise ukonyuka kwe-DA engaphandle ngexesha lokuvezwa kwento engafikelelekiyo kumfazi, kwaye onke amadoda angamadoda athatyathwa xa ibhinqa libekwa kwindawo yabo. Amadoda akhutshiwe kwi-2 iiveki ngaphambi kokuba abonise ukukhutshwa kwe-DA ekuphenduleni ibhinqa, kwaye akukho namnye owakhutshelwayo. Isibini kwisithathu se-1-veki eqeshwayo yenziwa kwaye yabonisa ukwanda kwe-DA, ngelixa isithathu esisele singazange silingise kwaye singakhange sibonise ukwanda kwe-DA. * P <.05, xa kuthelekiswa nesiseko se-testosterone yokuphathwa kwe-castrate; ** P <.01, xa kuthelekiswa nesiseko sokugqibela samadoda anganyangekiyo okanye i-castrate yokuphathwa kwezithuthi iveki enye; + P <.05, xa kuthelekiswa nesiseko sokugqibela se-castrate yokuphathwa kwezithuthi ezingaphumelelanga ukulingisa. (Ishicilelwe kwakhona kwiRef.22Ngemvume.)

 

I-metabolites zeTestosterone zazisebenza ngokwahlukileyo ekubuyiseleni ukukhutshwa kwe-DA kwii-castrate zexesha elide [25]. I-Estradiol ibuyisele amanqanaba e-basal aqhelekileyo e-DA, kodwa hayi ukwanda kokuphendula kumfazi. I-Estradiol iphathwe i-castrate engenileyo, kodwa akukho namnye owabonisa iphethini yokuziphatha ye-ejuko. Nokuba i-dihydrotestosterone okanye imoto yeoyile egcinwe ikopi okanye isiseko okanye ukukhutshwa kwe-DA kukhuthazo. Nangona kunjalo, xa i-dihydrotestosterone yayilawulwa nge-estradiol, indibaniselwano ibuyise konke ukukopishwa kunye nokusisiseko kunye nokukhutshwa kwe-DA kukhuthazayo [25].

Nangona amanqanaba e-extracellular e-MPOA DA ephantsi kwiindawo ezinobunkunkqele kunokuba kunjalo kumadoda angamadoda amnyama, amanqanaba entracellular aphakamileyo kunamadoda angasebenziyo [26]. Ewe, bekukho unxibelelwano olubi phakathi kwezicubu (ezigciniweyo) zamanqanaba e-DA kunye nokukwazi ukulingisa [27]. Izilwanyana ezingahambisaniyo (i-dihydrotestosterone- kunye ne-castrate ephathwe ioyile) zazinamanqanaba aphezulu e-DA kunamaqela enza ikopi (i-estradiol−, i-estradiol + dihydrotestosterone-, kunye ne-testosterone yanyangwa i-castrate. Ke ngoko, ukugcinwa nokugcinwa kwe-DA kwi-MPOA kubalasele kakhulu kwiindawo ezinobunkunkqele njengoko kunjalo kumadoda amileyo; Ukunqongophala kweendawo zokuhlala akubikho kumgangatho wokuyila nokugcina i-DA, kodwa kubuchule babo bokukhulula iivenkile zabo ezininzi.

2.4. Indima ye-NO kwi-MPOA DA ukukhutshwa

Izifundo ngaphambili zazichaze ukuba ukukhutshwa kwe-DA kwi-striatum kwenziwa lula yi-NO [28, 29]. Ke ngoko, sivavanye ukuba HAYI ingaba nemiphumela efanayo kwi-MPOA. Ewe, umanduleli we-NO, i-L-arginine, ukwanda kwe-basal MPOA DA, kunye NO-synthase (NOS) umchasi weL-NMMA kunciphise ukukhutshwa [30]. Isithinteli esahlukileyo se-NOS, i-L-NAME, sithintele ukukhutshwa okwenziwe kwi-DA [31], isiphumo esasinxibelelaniswe yi-cGMP [32]. Ngapha koko, ukugonywa kwe-neuronal NOS (nNOS) kuncitshisiwe emva kokuphoswa kwaye kwavuselelwa ukulawulwa kwe-testosterone [33]. Ke ngoko, enye yeendlela apho i-testosterone incedisa ukopisho kukonyusa i-NNOS kwi-MPOA, ethi yona ikonyuse ukukhutshwa kwe-basal kunye nokukhuthaza kwabasetyhini ukukhutshwa kwe-DA kumadoda angasebenziyo kunye ne-testosterone yanyangwa.

2.5. Iziphumo zamava ezesondo

Ilebhu yethu iphinde yaphanda ngeziphumo zamava ezesondo. Amadoda anamava aphumelela “ngokusebenza ngakumbi.” Banamacala amafutshane okunyusa, ukungqengqa, kunye nokufakelwa kwaye bayakwazi ukukhenkceza ngamanani amancinci kunye nokuphazamiseka (kuhlaziywa kwi [20]). Ukuchaza nje i-rat yamadoda ephindaphindiweyo kwibhinqa elingaphantsi komfazi kuyanele ukuphucula amandla akhe okunyanzela kunye nokwandisa ukugonyelwa kwe-c-Fos kwi-MPOA ephakanyiswe yi-ejaculation enye [34]. AKUKHO namnye onokuguqula ezinye zeziphumo zeselula kumava. I-NOS inhibitor L-NAME, encinci kwi-MPOA, yathintela ukukhuselwa kwisini se-naïve yamadoda kwaye yanciphisa inani le-intromissions kunye ne-ejaculations kumadoda anamava ngokwesondo [35]. Xa yayilawulwa kwi-MPOA ngaphambi kokuchazwa kwento nganye kwesixhenxe kumfazi otyhidiweyo, yathintela iziphumo zokubonakalisa. Ngaphaya koko, ukugonyelwa kwe-NNOS kwi-MPOA kukonyuswa ngamava angokwesondo angaphambili [36]. Ke ngoko, ukunyuka kokungabikho kwemveliso kwi-MPOA, kunye nokunyuka kweziphumo zokukhutshwa kwe-DA, kunokunika ezinye zeziphumo eziluncedo kumava ezesondo.

2.6. Igalelo elisuka kwi-amygdala ye-medial ukuya kwi-MPOA

Okona kuphakamisa impendulo ye-MPOA ye-DA kumfazi kukufakelwa kwe-medial amygdala (MeA). UJuan Dominguez wenza izilonda ezinkulu ze-amygdala, eyaphelisa ikopi kwirhasi yamadoda [37]. Nangona kunjalo, i-microinjections ye-apomist ye-agonist ye-DA kwi-MPOA ibuyisele ngokupheleleyo ukukopishwa kuloo malume. Izilonda ezincinci ze-radiofreqency ye-MeA yalimala, kodwa ayitshitshisanga ikopi. Amanqanaba e-Basal MPOA DA awachaphazelekanga, kodwa ukunyuka kwe-DA ekuphenduleni kwabasetyhini kwavalwa.37] (jonga Umzobo 3). Ke ngoko, njengokubuyiselwa kwe-estradiol yokushicilela kwi-castrate [25], amanqanaba asezantsi e-MPOA e-DA ayanele ukukhula ngendlela engafakwanga, kodwa ke ukonyuka okunyuselwe kwinqanaba labasetyhini kwakufuneka ukukhutshwa ngokugqibeleleyo. Kwizilwanyana ezingafakwanga i-anesthetised, ukuvuselelwa kweekhemikhali kweMeA, isebenzisa ubudlakudla kunye ne-glutamate reuptake inhibitor, ukunyusa amanqanaba e-DA angaphandle kwi-MPOA, ukulinganisa isiphumo sokukhuphela [38] (jonga Ikhiwane. 4). Ke ngoko, enye indlela i-MeA ekhuthaza ukukopishwa kukonyusa ukukhutshwa kwe-DA kwi-MPOA.

Ikhiwane. 3    

Ikhiwane. 3

 

Izilonda ze-medy amygdala zithintela ukukhutshwa kwe-DA kwi-MPOA ngenxa yokuvezwa komfazi obekekileyo kunye nokopelo.. Amanqanaba amele iipesenti zotshintsho ukusuka kwisiseko (BL) ekuphenduleni ekuchaseni kwangaphambili komfazi (PRE), ngexesha lokulingisa (C1-C3) nasemva kokukopisha (POST). I-extracellular DA inyuke ngokukuko ngexesha lokuqhubela phambili kunye nokukopa kokuvavanywa kwezilwanyana ezinezilonda ze-sham kodwa hayi izilwanyana ezinesilonda se-MeA. Amaxabiso abonakalisiwe njengentsingiselo ± SEM. * P <.05; ** P <.01. (Ishicilelwe kwakhona ukusuka [37Ngemvume.)

 
Ikhiwane. 4    

Ikhiwane. 4

 

Amanqanaba e-DA kwidayalysate evela kwi-MPOA yezilwanyana ezifumana ukhuthazo lwe-MeA okanye i-motorinjection. Amanqanaba amele ukutshintsha kwe-% ukusuka kusiseko (i-BL) ekuphenduleni kwi-MeA-stimulation okanye kwi-motorinjection yemoto; iisampulu eziqokelelwe emva kwee-microinjections kwi-MeA ziisampulu zokufaka inaliti 1 - 6 (P1 - P6). Amanqanaba e-extracellular DA anyuke kakhulu emva kwe-MeA microinjection yezilwanyana ezifumana ukhuthazo lwe-MeA kodwa hayi kwizilwanyana ezifumana isithuthi. Amaxabiso abonakalisiwe njengentsingiselo ± SEM. (* P <.05) (Ishicilelwe kwakhona ukusuka [38Ngemvume.)

 

2.7. Ukugcwala kwi-MPOA

Umlamli omnye wokukhutshwa kwe-DA kwi-MPOA glutamate [39]. Ikhutshwe kwi-MPOA ngexesha lokukhuphela, kwaye inyuka malunga ne-300% ngexesha le-ejaculation [40]. Ukubuyela umva kwe-dialysis ye-glutamate reuptake inhibitors kwandise glutamate engaphandle, njengoko kulindelekile, kwaye nako ukuqhuba. Nangona kunjalo, ukuphinda kuchwe kwakhona kwi-serotonin (5-HT) kwi-MPOA kuphazamise ukukhutshwa kokubini kunye ne-ejaculation-induced glutamate ukukhutshwa [41]. Ke ngoko, indawo yesibini apho i-5-HT inokuthi ithintele ukukhula kwayo yi-MPOA, apho inokunciphisa ukukhutshwa kwe-glutamate.

Inkcazo enokwenzeka yesiphumo sokuququzelela se glutamate kwiDA kubandakanya NO. I-NNOS inhibitor L-NAME, xa iphinde yarhuqwa yangena kwi-MPOA, yanciphisa isiseko kwi-DA kwaye yavala ukukhutshwa kwe-DA yokukhutshwa. I-isomer D-NAME engasebenziyo ayinasiphumo. I-Glutamate ibophelela kwii-receptors ze-NMDA ukukhuthaza i-calcium protocol, eyenza i-calmodulin, yona isebenze i-nNOS. AKUKHO namnye umntu onokuthintela i-DA ukuba ithathe itheminali ebumelwaneni, yandise imiphumo yayo, kwaye ingakhuthaza ukuvuza okuvaliweyo, okwandayo ukukhutshwa kwe-DA ngqo (kuhlolisiswe i- [42]). Ke ngoko, glutamate, ngokukhuthaza kwayo i-NNOS, inyusa ukukhutshwa kwe-DA kwi-MPOA, ethi yona iququzelele ukopisho. I-MPOA glutamate nayo inokunceda ukukhupha i-ejaculation.

3. isishwankathelo

Ngamafutshane, uBart Hoebel udale "umfanekiso omkhulu" weendawo zobuchopho eziphembelela imbuyekezo yendalo kunye neziyobisi zokuxhatshazwa. Ngokusebenzisa amandla ombane, izilonda, i-microinjection, i-Microphicalism, kunye ne-immunohistochemistry, kunye nokujonga ngononophelo nangokucwangcisiweyo kokuziphatha, wabeka imephu kwindawo zobuchopho kunye nee-neurotransmitters ezilawula ukondla, ukukhula, ubundlongondlongo, ukuthatha iziyobisi, kunye nomvuzo. I-Hull lab ilandelele ezinye zezo zimvo, kubandakanya ukusebenzisana phakathi kwe-LH kunye nenkqubo ye-mesocorticolimbic ye-DA. Sicebise ukuba i-5-HT kwi-LV ifunekayo inokuthi ithintele indlela yokuziphatha ngokwesondo ngokuthintela i-neurons ye-OX / HCRT, eya kuthi ngenye indlela icenge ii-neurons ze-DA kwiVTA. Sifunde ikakhulu indlela yokuziphatha ngokwesondo yamadoda, ukubonisa ukuba ama-testosterone kunye namava ezesondo anyusa i-NNOS kwi-MPOA, kwaye ukuba isiphumo sokunyuka kwe-NO yemveliso sinokunyusa ukukhutshwa kwe-basal kunye nokuvuselelwa kwabasetyhini. Ngaphaya koko, glutamate nayo ikhutshwa kwi-MPOA ngexesha lokukhwelana, ngakumbi ngexesha lokukhupha, kunye nokuzonwabisa, ukubamba ngee-receptors ze-NMDA kunye nokungena kwe-calcium, kunokunyusa i-NO, kwaye ke ukukhutshwa kwe-DA. Sityala kakhulu lempumelelo yethu, ingekuko kuphela ukuba nguBart Hoebel onguvulindlela osebenzisa ubuchwephetsha bokuchwetheza nezinye iindlela, kodwa nasekugxininiseni kwakhe kwinkqubo ye-neural kunye nokuhlangana kweendawo zobuchopho kunye nee-neurotransmitters.

Okokugqibela, kufanelekile ukuba uBart Hoebel aphumelele intshatsheli yemozulu efudumeleyo, exhasayo, eyoyikisayo, edibeneyo, neyonwabisayo kwisayensi nakwimpilo yakhe. Kuluyolo olukhulu ukwazi, ukunxibelelana naye, nokufunda kuye.

Imibulelo

Uphando olwenziweyo apha luxhaswe yi-NIH isibonelelo se-MH040826 kwi-EM Hull.

Imihlathi

Iphepha elichazayo ukuba awusenanto oyifunayo: Le fayili yeFayile yombhalo wesandla ongabhalwanga owamkelwe ukushicilelwa. Njengenkonzo kumakhasimende ethu sinika le ngcaciso yokuqala kwincwadi yesandla. Umbhalo wesandla uza kufumana ukukopishwa, ukufakela, nokuphonononga ubungqina obunokubakho ngaphambi kokuba kukhutshwe kwifomu yayo yokugqibela. Nceda uqaphele ukuba ngexesha lokuveliswa kweeprogram ezinokuthi zifumaneke ezinokuthi ziphazamise umxholo, kunye nazo zonke izisemthethweni ezichasayo ezisetyenziswa kwiphephancwadi.

Ucaphulo

1. I-Hoebel BG, Teitelbaum P. Ulawulo lwe-Hypothalamic yokondla kunye nokuzikhuthaza. Sayensi. 1962;135: 375-377. [PubMed]
2. I-Caggiula AR, iHoebel BG. "Indawo yokufumana umvuzo" kwi-hypothalamus yangemva. Sayensi. 1966;153: 1284-1285. [PubMed]
3. Zemlan FP, Trulson ME, Howell R, Hoebel BG. Impembelelo ye-p-chloroamphetamine kwizibonakaliso zesondo zabasetyhini kunye namanqanaba engqondo ye-monoamine. Res Resin. 1977;123: 347-356. [PubMed]
4. UHernandez L, uHoebel BG. Ukutya kunye nokunyusa kwe-hypothalamic kwandisa inzuzo ye-dopamine kwi-accumbens. Physiol Behav. 1988;44: 599-606. [PubMed]
5. UHernandez L, Hoebel BG. Ukondla kunokuphucula ukuvela kwe-dopamine kwi-cortex yangaphambili. Brain Res Bull. 1990;25: 975-979. [PubMed]
6. UHernandez L, uHoebel BG. Umvuzo wokutya kunye ne-cocaine kwandisa i-dopamine ye-extracellular kwi-nucleus accumbens njengoko kulinganiswa yi-microdialysis. Life Sci. 1988;42: 1705-1712. [PubMed]
7. Parada MA, Puig de Parada M, Hoebel BG. Amagundane azithiba intsholongwane kwi-dopamine antagonist kwi-lateral hypothalamus apho inyusa khona into eyongezelelweyo kwi-dopamine kwi-dopamine ye-extracellular. I-Pharmacol Brain Behav. 1995;52: 17987.
8. I-Lorrain DS, Matuszewich L, Friedman R, Hull EM. I-extracellular serotonin kwindawo ye-hypothalamic ye-lateral iyonyuswa ngexesha lokuphumla kwe-postejaculatory kunye nokungahambi kakuhle kwiigundane zesilisa. J Neurosci. 1997;17: 9361-9366. [PubMed]
9. Schwartz DH, McClane S, Hernandez L, Hoebel BG. Ukondla kunyusa i-extracellular serotonin kwi-hypothalamus yecala elisezantsi njengoko ilinganiswa nge-micodialysis. Res Resin. I-1989 Feb 13;479: 349-354. [PubMed]
10. Zemlan FP, Trulson ME, Howell R, Hoebel BG. Impembelelo ye-p-chloroamphetamine kwizibonakaliso zesondo zabasetyhini kunye namanqanaba engqondo ye-monoamine. Res Resin. 1977;123: 347-356. [PubMed]
11. I-Lorrain DS, Matuszewich L, Riolo JV, Hull EM. I-lateral hypothalamic serotonin inhibits nucleus accumbens dopamine: Iziphumo zokungqinelani ngokwesondo. J Neurosci. 1999;19: 7648-7652. [PubMed]
12. Li Y, Gap XB, Sakurai T, van den Pol AN. I-Hypocretin / i-orexin inceda ii-hypocretin neurons ngokusebenzisa indawo ye-glutamate neuron yendawo - Inkqubo enokubakho yokuhlengahlengisa inkqubo ye-hypothalamic arousal system. Neuron. 2002;36: 1169-1181. [PubMed]
13. Kotz CM. Umdibaniso wokondla kunye nokuzilolonga okwenziwa ngomzimba: indima ye-orexin. Physiol Behav. 2006;88: 294-301. [PubMed]
14. Thorpe AJ, Cleary JP, Levine AS, Kotz CM. I-orexinA ehanjiswa ngaphakathi. Inyusa inkuthazo yeepellets ezimnandi kwiigundane. Psychopharmacology (Berl) 2005;182: 75-83. [PubMed]
15. I-Sutcliffe JG, de Lecea L. Ii-hypocretins: ukubeka umqobo ovuselelayo. Nat Rev Neurosci. 2002;3: 339-349. [PubMed]
16. I-Saper CB, i-Scammell TE, uLu J. Hypothalamic ummiselo wokulala kunye nemigqi yokujikeleza. Uhlobo. 2005;437: 1257-1263. [PubMed]
17. UFad J, u-Deutch AY. I-anatomical substrates zokunxibelelana kwe-orexin-dopamine: uqikelelo lwe-hypothalamic yamuva kwindawo yecandelo le-ventral. Neuroscience. 2002;111: 379-387. [PubMed]
18. I-Narita M, Nagumo Y, Hashimoto S, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S, Suzuki T. Ukubandakanyeka ngqo kweenkqubo ze-orexinergic kwindlela yokusebenza ye-mesolimbic dopamine yendlela kunye nokuziphatha okunxulumene noko okubangelwa yi-morphine. J Neurosci. 2006;26: 398-405. [PubMed]
19. Muschamp JW, Dominguez JM, Sato SM, Shen RY, Hull EM. Indima ye-Hypocretin (Orexin) kuZowesilisa oziphethe kakubi ngokwesondo. J Neurosci. 2007;27: 2837-2845. [PubMed]
20. IHull EM, URodriguez-Manzo G. Amakhulu, ubuchopho kunye nokuziphatha. UHlelo lwesiBini. Umqu. 1. UDonald Pfaff, uMhleli-weNtloko, eAmsterdam: Elsevier Press; 2009. Umntu oziphethe kakuhle ngokwesondo; I-5-65.
21. UMiller SM, uLonstein JS. Iingcambu zeDopaminergic kwiindawo eziphambili zeengqungquthela zee-postpartum. Neuroscience. 2009;159: 1384-1396. [Inkcazelo yamahhala ye-PMC] [PubMed]
22. I-Hull EM, i-Du J, i-Lorrain DS, i-Matuszewich L. I-dopamine ye-extracellular dopamine kwindawo ye-medial preoptic: Iimpembelelo zezisusa zesini kunye nokulawulwa kwehormoni. J Neurosci. 1995;15: 7465-7471. [PubMed]
23. Sato S, Hull EM. Indlela ye-nitric oxide-cGMP ilawula i-dopamine efflux kwindawo ye-medial preoptic kunye nokukhutshelwa kwiigundane zesilisa. Neuroscience. 2006;139: 417-428. [PubMed]
24. UPutnam SK, uDu J, uHull EM. Ukubuyiswa kwe-testosterone yokukhutshelwa kunye nokukhululwa kwe-dopamine ye-medial preoptic kwiigundane zamadoda ezihanjisiweyo: i-2-, 5-, kunye ne-10-day day. UHorm Behav. 2001;39: 216-224. [PubMed]
25. Putnam SK, Sato S, Hull EM. Ulondolozo lwehormonal yokuqunjelwa kwiindawo ezinobungakanani: Umbutho kunye ne-extracellular dopamine kwi-MPOA. UHorm Behav. 2003;44: 419-426. [PubMed]
26. UDu J, uLorrain DS, uHull EM. Ukujikeleza kwehlisa i-extracellular, kodwa yonyusa i-intracellular, dopamine kwindawo ye-medial preoptic yeerhasi zamadoda. Res Resin. 1998;782: 11-17. [PubMed]
27. UPutnam SK, uSato S, uRiolo JV, uHull EM. Iziphumo ze-testosterone metabolites ekukhupheleni, kwi-dopamine ye-medial preoptic, kunye ne-NOS-immunoreac umsebenzi kwiigundane zamadoda ezihanjisiweyo. UHorm Behav. 2005;47: 513-522. [PubMed]
28. I-Zhu XZ, iLuo LG. Iziphumo zeNitroprusside (nitric oxide) kukhutshelo lwedopamine ye-endo native ukusuka kwizintyi zerat. J Neurochem. 1992;59: 932-935. [PubMed]
29. IHanbauer I, uWink D, u-Osawa Y, u-Edelman GM, uGally JA. Indima ye-nitric oxide kwi-NMDA-ekhutshwe yi-[3H] -i-dopamine kwimigca ye-striatal. NeuroReport. 1992;3: 409-412. [PubMed]
30. I-Lorrain DS, iHull EM. I-nitric oxide yonyusa i-dopamine kunye nokukhululwa kwe-serotonin kwindawo ye-medial preoptic. NeuroReport. 1993;5: 87-89. [PubMed]
31. I-Lorrain DS, Matuszewich L, Howard RV, Du J, Hull EM. I-nitric oxide ikhuthaza ukukhutshwa kwe-medial preoptic dopamine ukukhutshwa ngexesha lokulinganisa kwamadoda. NeuroReport. 1996;8: 31-34. [PubMed]
32. Sato S, Hull EM. Indlela ye-nitric oxide-cGMP ilawula i-dopamine efflux kwindawo ye-medial preoptic kunye nokukhutshelwa kwiigundane zesilisa. Neuroscience. 2006;139: 417-428. [PubMed]
33. UDu J, uHull EM. Iziphumo ze testosterone kwi-neuronal nitric oxide synthase kunye ne-tyrosine hydroxylase. Res Resin. 1999;836: 90-98. [PubMed]
34. I-Lumley LA, iHull EM. Iziphumo zomntu ochasayo we-D1 kunye namava ezesondo kwi-FOS-efana ne-immunoreactivity kwi-medial preoptic nucleus. Res Resin. 1999;829: 55-68. [PubMed]
35. ILagoda G, Vigdorchik A, Muschamp JW, Hull EM. I-nitric oxide synthase inhibitor kwi-MPOA inqanda ukunyanzeliswa kunye nokuvuselela uvakalelo kwimigundwane yamadoda. Behav Neurosci. 2004;118: 1317-1323. [PubMed]
36. UDominguez JM, uBrann JH, uGil M, uHull EM. Amava ezesondo akhulisa i-nitric oxide synthase kwindawo ye-medial preoptic yeerats zesilisa. Behav Neurosci. 2006;120: 1389-1394. [PubMed]
37. UDominguez J, uRiolo JV, u-Xu Z, uHull EM. Ummiselo yi-medial amygdala yokukhuphela kunye nokukhululwa kwe-dopamine ye-medial preoptic. J Neurosci. 2001;21: 349-355. [PubMed]
38. Dominguez JM, Hull EM. Ukuvuselelwa kwe-medial amygdala kuphucula ukukhutshwa kwe-medial preoptic dopamine ukukhutshwa: Iziphumo zokuziphatha kwendoda yesini. Res Resin. 2001;917: 225-229. [PubMed]
39. UDominguez JM, Muschamp JW, Schmich JM, Hull EM. Ukukhutshwa kwe-dopamine ye-glutamate-evoked dopamine kwindawo ye-medial preoptic yangaphakathi kunye ne-nitric oxide: Iziphumo zokuziphatha kwendoda yesini. Neuroscience. 2004;125: 203-210. [PubMed]
40. Dominguez JM, Gil M, Hull EM. Ubungcwangube obonakalayo kuqala. J Neurosci. 2006;26: 1699-1703. [PubMed]
41. Dominguez JM, Hull EM. I-Serotonin ibona ukuba ngumsebenzi wokudambisa-inkuthazo kwi-medial preoptic. Behav Neurosci. 2010;241: 554-557. [PubMed]
42. I-Prast H, i-Phillipu A. I-Nitric oxide njengemodyuli yomsebenzi we-neuronal. Prog Neurobiol. 2001;64: 51-68. [PubMed]